Children who receive mismatched unrelated donor bone marrow transplants (UD-BMT) have a significantly increased incidence of graft rejection but similar survival.

被引：0
|
作者：
Pamphilon, DH
Green, A
Sage, D
Cornish, JM
Steward, C
Potter, MN
Oakhill, A
机构：
[1] NATL BLOOD SERV BRISTOL,BRISTOL,AVON,ENGLAND
[2] ROYAL HOSP SICK CHILDREN,BRISTOL BS2 8BJ,AVON,ENGLAND
来源：
EXPERIMENTAL HEMATOLOGY | 1996年 / 24卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：662 / 662
页数：1
相关论文
共 11 条
  • [1] RATE OF ENGRAFTMENT AND INCIDENCE OF GVHD IN UNRELATED DONOR BONE-MARROW TRANSPLANTS (UD-BMT) WITH CAMPATH PURGED GRAFTS
    HUDSON, JG
    PAMPHILON, DH
    YOUSAF, SM
    CORNISH, JM
    OAKHILL, A
    EXPERIMENTAL HEMATOLOGY, 1993, 21 (08) : 1061 - 1061
  • [2] Gram negative bacteraemia (GNB) after 428 unrelated donor bone marrow transplants (UD-BMT): Risk factors, prophylaxis, therapy and outcome.
    Mitchell, A
    Derrington, P
    Turner, P
    Oakhill, A
    Marks, D
    BLOOD, 2001, 98 (11) : 206A - 206A
  • [3] Gram-negative bacteraemia (GNB) after 428 unrelated donor bone marrow transplants (UD-BMT): risk factors, prophylaxis, therapy and outcome
    Mitchell, AE
    Derrington, P
    Turner, P
    Hunt, LP
    Oakhill, A
    Marks, DI
    BONE MARROW TRANSPLANTATION, 2004, 33 (03) : 303 - 310
  • [4] Gram-negative bacteraemia (GNB) after 428 unrelated donor bone marrow transplants (UD-BMT): risk factors, prophylaxis, therapy and outcome
    A E Mitchell
    P Derrington
    P Turner
    L P Hunt
    A Oakhill
    D I Marks
    Bone Marrow Transplantation, 2004, 33 : 303 - 310
  • [5] Children with acute lymphoblastic leukemia who receive T-cell-depleted MLA mismatched marrow allografts from unrelated donors have an increased incidence of primary graft failure but a similar overall transplant outcome
    Green, A
    Clarke, E
    Hunt, L
    Canterbury, A
    Lankester, A
    Hale, G
    Wadmann, H
    Goodman, S
    Cornish, JM
    Marks, DI
    Steward, CG
    Oakhill, A
    Pamphilon, DH
    BLOOD, 1999, 94 (07) : 2236 - 2246
  • [6] Enriched CD34+ bone marrow cells with isolex 300 (Baxter(TM)) devices reduce severe graft-versus-host disease (GVHD) in allogeneic bone marrow transplantation with unrelated donor (UD-BMT)
    Esperou, H
    Marolleau, JP
    Rocha, V
    Dalcortivo, L
    Sedki, M
    Parquet, N
    Raffoux, C
    Traineau, R
    Socie, G
    Benbunan, M
    Gluckman, E
    BLOOD, 1997, 90 (10) : 483 - 483
  • [7] HLA-mismatched BMT from unrelated donors (UD) in children with all does not affect BMT-related mortality, chronic GVHD or long term survival but is associated with an increased incidence of primary graft failure.
    Green, A
    Hunt, L
    Lankester, A
    Hale, G
    Waldman, H
    Goodman, S
    Cornish, JM
    Steward, CG
    Marks, DI
    Oakhill, A
    Pamphilon, DH
    BONE MARROW TRANSPLANTATION, 1999, 23 : S178 - S178
  • [8] IMPACT OF HLA CLASS-II DNA TISSUE TYPING ON ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD) AND SURVIVAL IN UNRELATED DONOR BONE-MARROW TRANSPLANTS (BMT)
    GAJEWSKI, J
    CECKA, M
    TONAI, R
    PRZEPIORKA, D
    FEIG, S
    TERASKI, P
    FISCHER, H
    GIRALT, S
    VANBESIEN, K
    CHAN, K
    HUNT, L
    IPPOLITI, C
    MEHRA, R
    KHOURI, I
    ANDERSSON, B
    DEISSEROTH, A
    NIMER, S
    SCHILLER, G
    LILL, M
    WOLIN, M
    BEEBE, M
    VONWOLFF, B
    TERRITO, M
    GJERTSON, D
    CHAMPLIN, R
    BLOOD, 1994, 84 (10) : A393 - A393
  • [9] AGE-RELATED SURVIVAL AND ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD) INCIDENCE OF UNRELATED DONOR BONE-MARROW TRANSPLANTS FOR ADVANCED LEUKEMIA AND MYELODYSPLASIA
    GAJEWSKI, J
    GOODMAN, LA
    OROURKE, S
    HUNT, L
    LANDAW, E
    SCHILLER, G
    TERRITO, M
    NIMER, S
    FEIG, S
    EXPERIMENTAL HEMATOLOGY, 1993, 21 (08) : 1106 - 1106
  • [10] Increased Incidence of Chronic Graft-Versus-Host Disease (GVHD) and No Survival Advantage with Filgrastim-Mobilized Peripheral Blood Stem Cells (PBSC) Compared to Bone Marrow (BM) Transplants From Unrelated Donors: Results of Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Protocol 0201, a Phase III, Prospective, Randomized Trial
    Anasetti, Claudio
    Logan, Brent R.
    Lee, Stephanie J.
    Waller, Edmund K.
    Weisdorf, Daniel J.
    Wingard, John R.
    Cutler, Corey S.
    Westervelt, Peter
    Woolfrey, Ann
    Couban, Stephen
    Johnston, Laura
    Maziarz, Richard T.
    Pulsipher, Michael
    Anderlini, Paolo
    Bensinger, William I.
    Leitman, Susan F.
    Rowley, Scott D.
    Carter, Shelly L.
    Horowitz, Mary M.
    Confer, Dennis L.
    BLOOD, 2011, 118 (21) : 3 - 3
12